Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)

Insel Gruppe AG, University Hospital Bern

Status: Not yet enrolling

Conditions: Retinal Disease

Treatments: Device: OCT/FLIM

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05819307

STARFLI

Details and patient eligibility

About

To investigate the feasibility of a combined OCT/FLIM device

Full description

To investigate the feasibility of a combined Optical coherence tomography/ Fluorescence Lifetime Measurement (OCT/FLIM) device.

Enrollment: 70 estimated patients

Sex: All

Ages: 18 to 120 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subject must be willing to give written informed consent
• Age: Patients and Probands 18 years or greater
• Both eyes will be assessed in the study

Exclusion criteria

• Patients not willing or able to sign informed consent
• Patients younger than 18 years
• Patients with epilepsy